Matthew Roberts, PHD., MBA, spanning multiple decades in multinational and emerging market companies has joined the firm to build capability in its new Chief Science Officer practice.

Matthew Roberts, PHD

Dr. Matthew Roberts has over 25 years of success in driving corporate growth through science, technology, innovation, operations as a C-Level executive and as a trusted advisor. He currently manages a portfolio of growth-phase companies, while historically having worked with large multinationals at Pharmavite, The Nature’s Bounty Company, Abbott Nutrition, and Nestlé. He has served on the board or as a trusted advisor to a number of emerging food, beverage, and pharmaceutical companies. Examples include the Nutrition Capital Network, WellVest, ChromaDex, Pierre Marcolini, VetCentric, Attune Foods, and others.

Builds Capability in Executive Acquisition, Development, and Organizational Advisory

As a 10-year operating executive in two F500 companies, two multi-billion dollar nutrition companies, as well as numerous early-stage companies, Dr. Roberts brings extensive insights to Boards, CEOs, and functional leaders on how to design, hire, and deliver world-class leadership in technical, quality, operational, and scientific functions. Matthew has a strong track record of developing talent, coaching emerging leaders, and designing organizations to exceed performance expectations. The authenticity of Dr. Roberts’ experience will help Boards and CEOs wade through investment and leadership tradeoffs, hype vs reality, creating value, improving organizational effectiveness, and delivering growth through innovation.

Having the breadth of Dr. Roberts’ leadership experience is a game changer for our clients. We can immediately advise a broader set of clients on how technical and scientific teams could be assessed, led, and structured” said Jeff DeFazio, Managing Partner, and Founder.

Three Decades Subject Matter Expertise – Digital Health, Food, Nutrition

As a testament to his technical capability, Dr. Roberts’ teams have authored hundreds of patents and peer review publications. These results occurred from his time as CSO / CTO at Nature’s Bounty, Pharmavite, and Health & Happiness, CSO and Scientific Advisory Board member at Chromadex. Prior to his C-suite roles, Dr. Roberts was Divisional Vice President of Global Product Development at Abbott Labs and Assistant Vice President of Corporate Venture Capital at Nestlé.

“He’s one of the earlier pioneers that began using advanced chemical and life science technology to drive innovation in new product development and efficacy”, said DeFazio.

“The multi decade operating experiences of all the partners at Carpe Diem was quite important. Here, I am working side by side with like-minded colleagues focused on solving complex client problems be it at scale, or emerging businesses. They think and behave like operating leaders, not consultants. The culture of transparency, collaboration, and accountability to clients and colleagues is consistent with my values”, said Dr. Roberts.

Dr. Roberts has a PHD from Cornell University, Environmental and Comparative Toxicology, an MBA from Olin School of Business, Washington University, and an undergraduate from Purdue University, Plant Molecular Biology and Physiology.

About Carpe Diem Global Partners

Carpe Diem Partners

Carpe Diem Global Partners is a bespoke consultancy focused on Talent Advisory Services across Executive Acquisition, Leadership Development, and Organizational Advisory Services. The firm works closely with Boards, Chief Executives, and Senior-Level Executives, advising Public, Private, and Investor-backed companies on leadership imperatives. Headquartered in San Francisco, CA with national and global experience.

For more information, contact us at info@carpediempartners.com.